Heart Valve Devices Market Size to Hit USD 40.16 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Heart Valve Devices Market

5.1. COVID-19 Landscape: Heart Valve Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Heart Valve Devices Market, By Type of Heart Valve

8.1. Heart Valve Devices Market Revenue and Volume Forecast, by Type of Heart Valve

8.1.1. Aortic Valve

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Mitral Valve

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Tricuspid Valve

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Pulmonary Valve

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Heart Valve Devices Market, By Material

9.1. Heart Valve Devices Market Revenue and Volume Forecast, by Material

9.1.1. Biological Valve

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Mechanical Valve

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Heart Valve Devices Market, By Age Group

10.1. Heart Valve Devices Market Revenue and Volume Forecast, by Age Group

10.1.1. Pediatric Patients

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Adults

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Geriatric Patients

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Heart Valve Devices Market, By End-User

11.1. Heart Valve Devices Market Revenue and Volume Forecast, by End-User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Home Care

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Heart Valve Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.1.2. Market Revenue and Volume Forecast, by Material

12.1.3. Market Revenue and Volume Forecast, by Age Group

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.1.5.2. Market Revenue and Volume Forecast, by Material

12.1.5.3. Market Revenue and Volume Forecast, by Age Group

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.1.6.2. Market Revenue and Volume Forecast, by Material

12.1.6.3. Market Revenue and Volume Forecast, by Age Group

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.2.2. Market Revenue and Volume Forecast, by Material

12.2.3. Market Revenue and Volume Forecast, by Age Group

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.2.5.2. Market Revenue and Volume Forecast, by Material

12.2.5.3. Market Revenue and Volume Forecast, by Age Group

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.2.6.2. Market Revenue and Volume Forecast, by Material

12.2.6.3. Market Revenue and Volume Forecast, by Age Group

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.2.7.2. Market Revenue and Volume Forecast, by Material

12.2.7.3. Market Revenue and Volume Forecast, by Age Group

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.2.8.2. Market Revenue and Volume Forecast, by Material

12.2.8.3. Market Revenue and Volume Forecast, by Age Group

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.3.2. Market Revenue and Volume Forecast, by Material

12.3.3. Market Revenue and Volume Forecast, by Age Group

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.3.5.2. Market Revenue and Volume Forecast, by Material

12.3.5.3. Market Revenue and Volume Forecast, by Age Group

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.3.6.2. Market Revenue and Volume Forecast, by Material

12.3.6.3. Market Revenue and Volume Forecast, by Age Group

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.3.7.2. Market Revenue and Volume Forecast, by Material

12.3.7.3. Market Revenue and Volume Forecast, by Age Group

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.3.8.2. Market Revenue and Volume Forecast, by Material

12.3.8.3. Market Revenue and Volume Forecast, by Age Group

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.4.2. Market Revenue and Volume Forecast, by Material

12.4.3. Market Revenue and Volume Forecast, by Age Group

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.4.5.2. Market Revenue and Volume Forecast, by Material

12.4.5.3. Market Revenue and Volume Forecast, by Age Group

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.4.6.2. Market Revenue and Volume Forecast, by Material

12.4.6.3. Market Revenue and Volume Forecast, by Age Group

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.4.7.2. Market Revenue and Volume Forecast, by Material

12.4.7.3. Market Revenue and Volume Forecast, by Age Group

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.4.8.2. Market Revenue and Volume Forecast, by Material

12.4.8.3. Market Revenue and Volume Forecast, by Age Group

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.5.2. Market Revenue and Volume Forecast, by Material

12.5.3. Market Revenue and Volume Forecast, by Age Group

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.5.5.2. Market Revenue and Volume Forecast, by Material

12.5.5.3. Market Revenue and Volume Forecast, by Age Group

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type of Heart Valve

12.5.6.2. Market Revenue and Volume Forecast, by Material

12.5.6.3. Market Revenue and Volume Forecast, by Age Group

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. Medtronic plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Boston Scientific Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Edwards Lifesciences Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Foldax Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Novostia SA

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Meril Life Sciences Pvt. Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Corcym UK Limited

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. JenaValve Technology, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Micro Interventional Devices, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Auto Tissue Berlin GmbH

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global heart valve devices market is expected to increase from USD 13.34 billion in 2024 to USD 40.16 billion by 2034.

The heart valve devices market is expected to grow at a compound annual growth rate (CAGR) of around 11.65% from 2025 to 2034.

The major players in the heart valve devices market include Medtronic plc, Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, Foldax Inc., Novostia SA, Meril Life Sciences Pvt. Ltd., Corcym UK Limited, JenaValve Technology, Inc., Micro Interventional Devices, Inc., Auto Tissue Berlin GmbH, Anteris Technologies Ltd, Thubrikar Aortic Valve, Inc., MicroPort Scientific Corporation, and Biosensors International Group, Ltd.

The driving factors of the heart valve devices market are the increased awareness of heart valve diseases, favorable reimbursement policies, and greater access to diagnosis.

North America region will lead the global heart valve devices market during the forecast period 2025 to 2034.